Commercial feasibility of a therapeutic approach to cancer based on ‘LEGO’ antibody recruiting glycodendrimers

Project Information

THERA-LEGO

Grant agreement ID: 963862

DOI

10.3030/963862

Project closed

EC signature date 27 November 2020

Start date 1 January 2021

End date 30 June 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

UNIVERSITE GRENOBLE ALPES
France

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Homo- and Heterovalent Neoglycoproteins as Ligands forBacterial Lectins

Author(s): David Goyard, Benoît Roubinet, Federica Vena, Ludovic Landemarre, and Olivier Renaudet
Published in: ChemPlusChem, 2022, ISSN 2192-6506
Publisher: Wiley-VCH Verlag
DOI: 10.1002/cplu.202100481